Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,204 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a Co-GP / Platform angle — each card surfaces how a family office could deploy capital in that market.
317 reports
Page 7 / 14- SavillsFeb 5, 2025
Philadelphia Q4 2024 Life Sciences Market Overview
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, focusing on established firms with a strong track record in the sector.
- CBREJan 31, 2025
Life Sciences Market Ends 2024 With Improved Absorption & New Leasing Activity
Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on those with a strong track record in leasing and absorption.
- CBREJan 31, 2025
San Diego Life Sciences Market Overview Q4 2024
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- CBREJan 29, 2025
Bay Area Life Sciences Figures Q4 2024
Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline.
- SavillsJan 24, 2025
Boston-Cambridge Q4 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and aligning interests with a sponsor focused on adaptable spaces.
- SavillsJan 24, 2025
San Diego Q4 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of potential projects.
- SavillsJan 24, 2025
San Francisco Bay Area Q4 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of life sciences projects.
- NewmarkJan 22, 2025
Boston Life Sciences Market Report 4Q24
Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a repeatable pipeline of lab space opportunities.
- NewmarkJan 20, 2025
Bay Area Life Science Market Report 4Q24
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong pipeline of leasing activity.
- CBREJan 17, 2025
Denver/Boulder Life Sciences Figures Q4 2024
Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.
- CBREJan 17, 2025
Philadelphia Life Sciences Figures Report Q4 2024
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.
- TranswesternJan 17, 2025
US Life Sciences Market Research Report - Q3 2024
Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor/operator at the GP level to capitalize on the anticipated recovery in venture funding and M&A activity.
- NewmarkJan 17, 2025
Boston Life Sciences Market Report 3Q24
Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator focused on laboratory space, leveraging the current venture capital resurgence to align interests and share in the promote.
- CBREJan 10, 2025
Greater Boston Life Science Figures Q4 2024
Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level to share in the promote and align interests.
- ColliersDec 11, 2024
2024 Philadelphia Life Sciences Market Report: Opportunity Post Uncertainty
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests.
- NewmarkDec 2, 2024
Bay Area Life Science Market Report 3Q24
Life ScienceFamily Office Briefing →Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests for long-term success.
- Cushman & WakefieldNov 27, 2024
Q3 2024 Raleigh Life Sciences Report
Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from a repeatable pipeline.
- ColliersNov 25, 2024
24Q3 Greater Boston Life Sciences Report
Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a robust pipeline of opportunities.
- CBRENov 13, 2024
Puget Sound Life Sciences Figures Q3 2024
Co-GP / Platform:A family office could deploy into the Puget Sound life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline.
- CBRENov 13, 2024
San Diego Life Sciences Market Overview Q3 2024
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- SavillsNov 8, 2024
San Francisco Bay Area Q3 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong development pipeline.
- SavillsNov 6, 2024
San Diego Q3 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor like Longfellow Real Estate or Alexandria Real Estate Equities at the GP level to share in the promote and benefit from their established pipelines.
- SavillsNov 6, 2024
Philadelphia Q3 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.
- SavillsNov 6, 2024
Boston-Cambridge Q3 2024 Life Sciences Market Report
Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor like Trammell Crow or Alexandria Real Estate Equities at the GP level to share in the promote and access a pipeline of high-quality developments.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.